| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4025959 | Ophthalmology | 2014 | 7 Pages |
Abstract
Infliximab induces a high rate of complete clinical remission in recalcitrant uveitis and is well tolerated by most patients.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jonathan N. MD, Paul MD, PhD, Ana M. MD, C. Stephen MD, FACS,